A ROS-responsive hydrogel encapsulated with matrix metalloproteinase-13 siRNA nanocarriers to attenuate osteoarthritis progression
Abstract RNA interference (RNAi) and oxidative stress inhibition therapeutic strategies have been extensively utilized in the treatment of osteoarthritis (OA), the most prevalent degenerative joint disease. However, the synergistic effects of these approaches on attenuating OA progression remain lar...
Saved in:
Main Authors: | Qiuyang Wang, Kai Feng, Guangsheng Wan, Wei Liao, Jing Jin, Peng Wang, Xiaolian Sun, Weijun Wang, Qing Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-024-03046-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipopolymers as the Basis of Non-Viral Delivery of Therapeutic siRNA Nanoparticles in a Leukemia (MOLM-13) Model
by: Panadda Yotsomnuk, et al.
Published: (2025-01-01) -
Nanotechnology in Drug Delivery: Anatomy and Molecular Insight into the Self-Assembly of Peptide-Based Hydrogels
by: Adelaide R. Mashweu, et al.
Published: (2024-11-01) -
A systematic review of nanocarriers used in medicine and beyond — definition and categorization framework
by: Sabine Gressler, et al.
Published: (2025-02-01) -
Lipid nanocarriers encapsulating herbal drugs for brain diseases therapy
by: Sara S. Gad, et al.
Published: (2023-06-01) -
The Potential Application of Nanocarriers in Delivering Topical Antioxidants
by: Zulfan Zazuli, et al.
Published: (2025-01-01)